The Associations between Body Shape Index and Dyslipidemia and Diabetes in Cardiovascular Patients

Background:

Background: Due to the importance of identifying and preventing non-communicable diseases, especially obesity and overweight, this study was performed to investigate the relationship between A Body Shape Index (ABSI) and dyslipidemia.

Objectives:

This study was performed to investigate the relationship between A Body Shape Index (ABSI) and dyslipidemia.

Methods:

This cross-sectional study was conducted on 300 patients. Eligible individuals were selected using convenience sampling. The participants’ height and waist circumference were measured. The results of these measurements as well as other demographic information, reason for referral, blood sugar, Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), Triglyceride (TG), and cholesterol levels, and blood pressure were recorded in a checklist that was designed based on the research objectives. The obtained data were then entered into the SPSS 11 software and analyzed using independent sample t-test and Pearson’s correlation coefficient at the 0.05 significance level.

Results:

This study was conducted on 300 patients with the mean age of 41.6 ± 7.17 years. The means of body mass index and ABSI were 27.10 ± 4.40 kg/m2 and 0.082 ± 0.006, respectively. The mean of ABSI was significantly higher in the patients who had high TG levels as well as sugar levels higher than 100 mg/dL compared to those with low TG and blood sugar levels (P = 0.03 and P = 0.02, respectively). However, this parameter was significantly lower in the patients with low HDL levels compared to those with high HDL levels (P = 0.02). ABSI was significantly correlated to fasting blood sugar (r = 0.15, P = 0.008) and TG (r = 0.12, P = 0.02).

Conclusion:

The study results indicated that ABSI was correlated to the serum levels of TG and fasting blood sugar. Additionally, the mean of ABSI was higher among the patients with diabetes compared to the others.